Soo Mi Lee in the Virology Program at Harvard Medical School, showed that cellular miR-127-3p suppresses KSHV-induced transformation and tumorigenesis via down-regulation of SKP2, identifying the miR-127-3p/SKP2 axis as a viable therapeutic avenue for Kaposi’s sarcoma [36]. This evidence concerns the gene SKP2 and Kaposi's sarcoma.